This website contains age-restricted materials including nudity and explicit depictions of sexual activity. By entering, you affirm that you are at least 18 years of age or the age of majority in the jurisdiction you are accessing the website from and you consent to viewing sexually explicit content.
One rainy Tuesday, Mira received a call that would change everything. Dr. Lucien Varga, the institute’s head virologist, asked her to meet in the at 0300 hours. The doors were guarded by a pair of men in black suits, their faces hidden behind reflective visors. Inside, the air smelled faintly of ozone and old paper.
“The fragment is 1.2 kilobases long,” Varga continued, “and it appears to be an RNA virus—highly mutable, with a polymerase that can splice itself into host genomes. The code is labeled NHDTA‑257. We’ve never seen the prefix before.”
Prologue The world had long since learned to trust the numbers on its medicine bottles more than the names on the labels. In the vaults beneath Geneva’s International Health Institute (IHI), a single, unassuming aluminum case sat on a steel shelf marked “NHDTA‑257 – AVi.” No one knew what the letters meant, and no one was allowed to ask. The case was sealed with a biometric lock, a tamper‑proof seal, and a single, blinking red light that pulsed like a slow, warning heartbeat. Chapter 1 – The Analyst Mira Patel had spent the last six years of her life in the sterile corridors of the IHI, sifting through terabytes of pathogen genomes, hunting for the next pandemic before it could find a host. She was a bio‑informatician, a quiet sort who could coax meaning out of a sea of nucleotides the way a composer coaxed melody from a single note. nhdta 257 avi
Mira swallowed. She had spent her career chasing whispers in data; now she would be chasing a ghost in a metal box. The case was heavier than Mira expected. When the biometric lock finally clicked, she lifted the lid and revealed a sleek, silver drone, its hull scarred with micro‑abrasions and a faint, phosphorescent glow emanating from its ventral panel. The AVi‑257 was a relic of the Aerial Viral Interface program—a secret joint project between the IHI and the International Space Agency (ISA) to deploy self‑replicating nanoviruses via high‑altitude drones, intended for planetary terraforming.
Rex, his mission finally complete, prepared to leave. He handed Mira a small, silver key. One rainy Tuesday, Mira received a call that
“ are still in the archives,” Varga muttered. “They can carry nanoliposomes. If we retrofit one, we can drop the protease into any environment—soil, water, even the atmosphere.”
He glanced at a steel door on the far wall. “The is still in storage. It was one of the last of its kind, a hybrid drone‑virus carrier. The case you see there is sealed for a reason. You’ll be the first to open it in twenty‑seven years.” The doors were guarded by a pair of
Rex nodded. “I still have the flight logs for the AVi‑257. I know the altitude, the dispersal vectors, the wind patterns. We can program a —a one‑use drone that will release the protease instead of the virus.” Chapter 6 – The Launch The IHI’s hangar was a cavernous space of concrete and steel, dimly lit by emergency lights. In the center stood a modified AVi‑258 —its hull painted matte black, its interior stripped of the viral cartridge and replaced with a sealed vial of synthesized protease P‑Δ, encased in a stabilizing nanoliposome matrix.